S2

Fig. S1 Relative in vitro translation efficiencies of NRAS UTR(-)Q, NRAS UTR(+)Q
and NRAS UTR(+120)Q mRNAs in the presence of the 20 and 40 µΜ of RR110, as measured by luciferase activities. For each construct, the measured luciferase activity was normalized to the activity obtained in the absence of the ligand, which was set as 100%. Experiments were performed at least three times using at least two separate batches of RNA. The average values are presented along with the standard error on the mean. a. The initial amplitudes are expressed in percentage of the total population after normalization by the sum of the initial amplitudes of the three phases.
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Scheme S1 General scheme for the synthesis of RR110. 
Dimethyl-4-(4-fluoro-benzyloxy)-pyridine-2,6-dicarboxylate (2)
The known 1 chelidamic acid dimethyl ester (1) (200 mg, 0.9 mmol), 4-fluorobenzyl alcohol (154 µl, 1.4 mmol) and triphenylphosphine (373 mg, 1.4 mmol)
were dissolved in freshly distilled THF (5 ml) then cooled to 0 °C. DIAD (325 µl, 1.7 mmol) was added dropwise under argon. The mixture was allowed to warm to rt and stirred for 3 days. The solvent was removed in vacuo and the product purified by S9 column chromatography (50% EtOAc, 50% petroleum ether) to obtain the title compound as a white powder (200 mg, 0.6 mmol, 67% petroleum ether) to obtain a white powder which was dissolved in DCM (1.5 ml) and TFA (0.5 ml) and stirred for 4 h at rt. The solvent was removed in vacuo to give a
